MDC medlab clinical limited

Ann: Australian Patent Granted for NanoCelle Delivery Platform, page-7

  1. 13 Posts.
    lightbulb Created with Sketch. 5
    This is from back in 2017 from Simply Wall Street, Insiders (Directors etc) held over 30% of shares on issue. They do not sell these from previous announcements so 30% of shares never move.

    17.8% of equities held is Insto, but I suspect this is higher than when this data was released due to offers over the last 3 years. THESE ARE PEOPLE WHO BOUGHT FOR LESS THAN SP, SO OFFLOAD FOR PROFITS.

    I will try to find more recent data but as retail investors who are bullish on the company dont sell and acquire more at lower prices. With low Liquidity you will see bigger swings but many of the holders are here for long hold and my personal view is, if it gets to 15c or lower I buy as many as I can purchase.

    Been considered a cannabis stock, you will have people trying to trade it for quick quick wins but as you all know this isn't the company for it.

    Getting patent confirmed is pretty big news, at beginning it will only be for Australia, but if they can get a similar patent from FDA, anyone trying to use the technology will have to pay them a royalty or licence fee.

    Do your own research

    BK


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.